Physician profile
Eugene S Ahn
NPI 1912999533
$1,080.03
in general payments reported to CMS, 2019-2025
9 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $87.77 · 2021: $119 · 2022: $143 · 2023: $135 · 2024: $271 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $547.33 | 2023-2025 | Orgovyx |
| Myovant Sciences INC. | $120.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $111.11 | 2019-2022 | |
| Novocure INC. | $100.25 | 2019-2023 | Optune |
| Pfizer INC. | $89.33 | 2020-2021 | |
| Intuitive Surgical, INC. | $37.97 | 2024 | |
| Ge Healthcare | $30.48 | 2021 | |
| Visionrt, INC. | $23.68 | 2019 | |
| Elekta, INC. | $19.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.